THR-317 - Further readings
Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1alpha-VEGF pathway inhibition.
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.
Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
Knockdown of the placental growth factor gene inhibits laser induced choroidal neovascularization in a murine model.
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy.
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
Protective Effects of Antiplacental Growth Factor Antibody Against Light-Induced Retinal Damage in Mice.
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives.